These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3412318)

  • 21. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.
    Niedzwicki JG; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uridine phosphorylase from Schistosoma mansoni.
    el Kouni MH; Naguib FN; Niedzwicki JG; Iltzsch MH; Cha S
    J Biol Chem; 1988 May; 263(13):6081-6. PubMed ID: 3360774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The binding of 3'-N-piperidine-4-carboxyl-3'-deoxy-ara-uridine to ribonuclease A in the crystal.
    Leonidas DD; Maiti TK; Samanta A; Dasgupta S; Pathak T; Zographos SE; Oikonomakos NG
    Bioorg Med Chem; 2006 Sep; 14(17):6055-64. PubMed ID: 16730994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of administration of 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase, on the anti-tumor efficacy of 5-fluoro-2'-deoxyuridine against murine colon tumor C26-10.
    Ashour OM; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
    Biochem Pharmacol; 2000 Sep; 60(5):687-92. PubMed ID: 10927027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The X-ray structure of Salmonella typhimurium uridine nucleoside phosphorylase complexed with 2,2'-anhydrouridine, phosphate and potassium ions at 1.86 A resolution.
    Lashkov AA; Zhukhlistova NE; Gabdoulkhakov AH; Shtil AA; Efremov RG; Betzel C; Mikhailov AM
    Acta Crystallogr D Biol Crystallogr; 2010 Jan; 66(Pt 1):51-60. PubMed ID: 20057049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal structures of Escherichia coli uridine phosphorylase in two native and three complexed forms reveal basis of substrate specificity, induced conformational changes and influence of potassium.
    Caradoc-Davies TT; Cutfield SM; Lamont IL; Cutfield JF
    J Mol Biol; 2004 Mar; 337(2):337-54. PubMed ID: 15003451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationships of 6-substituted androst-4-ene analogs as aromatase inhibitors.
    Numazawa M; Kamiyama T; Tachibana M; Oshibe M
    J Med Chem; 1996 May; 39(11):2245-52. PubMed ID: 8667367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyrimidine ribonucleoside phosphorylase activity vs 5- and/or 6-substituted uracil and uridine analogues, including conformational aspects.
    Krajewska E; Shugar D
    Biochem Pharmacol; 1982 Mar; 31(6):1097-102. PubMed ID: 7044382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
    Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S
    Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological activity of the potent uridine phosphorylase inhibitor 5-ethyl-2,2'-anhydrouridine.
    Veres Z; Szinai I; Szabolcs A; Ujszászy K; Dénes G
    Drugs Exp Clin Res; 1987; 13(10):615-21. PubMed ID: 3428126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationship of nucleobase ligands of uridine phosphorylase from Toxoplasma gondii.
    Iltzsch MH; Klenk EE
    Biochem Pharmacol; 1993 Nov; 46(10):1849-58. PubMed ID: 8250971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modulation of 5-fluorouracil host-toxicity and chemotherapeutic efficacy against human colon tumors by 5-(Phenylthio)acyclouridine, a uridine phosphorylase inhibitor.
    Al Safarjalani ON; Rais R; Shi J; Schinazi RF; Naguib FN; el Kouni MH
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):692-8. PubMed ID: 16528530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uridine phosphorylase inhibitors: chemical modification of benzyloxybenzyl-barbituric acid and its effects on urdpase inhibition.
    Guerin DJ; Mazeas D; Musale MS; Naguib FN; Al Safarjalani ON; el Kouni MH; Panzica RP
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1477-80. PubMed ID: 10386920
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uridine phosphorylase from Novikoff rat hepatoma cells: purification, kinetic properties, and its role in uracil anabolism.
    McIvor RS; Wohlhueter RM; Plagemann PP
    J Cell Physiol; 1985 Mar; 122(3):397-404. PubMed ID: 2981897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
    Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
    Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.
    Orr GF; Musso DL; Boswell GE; Kelley JL; Joyner SS; Davis ST; Baccanari DP
    J Med Chem; 1995 Sep; 38(19):3850-6. PubMed ID: 7562916
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line.
    Lang TT; Young JD; Cass CE
    Mol Pharmacol; 2004 Apr; 65(4):925-33. PubMed ID: 15044622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of pyrimidine nucleoside phosphorylase inhibitors on hepatic fluoropyrimidine elimination in the rat.
    LaCreta FP; Warren BS; Williams WM
    Cancer Res; 1989 May; 49(10):2567-73. PubMed ID: 2523758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory potency of 5-benzyluracil, 5-phenylcytosine and 5-phenylpyrimidin-2-one nucleosides against uridine phosphorylase from mouse leukemic L1210 cells.
    Votruba I; Krecmerová M; Hrebabecký H; Holý A
    Nucleosides Nucleotides; 1999; 18(11-12):2551-64. PubMed ID: 10639754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.